Evaluation of the Clinical Benefit of Cancer Drugs Submitted for Reimbursement Recommendation Decisions in Canada

IMPORTANCE: Cancer drugs approved by the US Food and Drug Administration have come under scrutiny for marginal clinical benefits; however, the clinical benefits of cancer drugs recommended for reimbursement in Canada have not been adequately studied. OBJECTIVE: To assess the differences in the clini...

Full description

Saved in:
Bibliographic Details
Published in:JAMA Intern Med
Main Authors: Meyers, Daniel E., Jenei, Kristina, Chisamore, Timothy M., Gyawali, Bishal
Format: Artigo
Language:Inglês
Published: American Medical Association 2021
Subjects:
Original Investigation
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7900938/
https://ncbi.nlm.nih.gov/pubmed/33616606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2020.8588
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items